Condition: Diabete Type 1 · Pregnancy Complications · Sponsor: Rigshospitalet, Denmark
A national multi-center open-label randomized controlled trial that investigates whether the use of the automated insulin delivery system CamAPS FX initiated during pregnancy planning or in early pregnancy improves maternal time in glycemic targets and fetal growth in women with type 1 diabetes compared to usual insulin treatment modality combined with Continuous Glucose Monitoring.
This description comes directly from the study's public registry record.
Lene Ringholm Chief physician, PhD, Associate Professor · +45 35458671 · lene.ringholm.02@regionh.dk
Always discuss trial participation with your own doctor first.
| Department of Gynecology and Obstetrics, Aalborg University Hospital | Aalborg, Aalborg, Denmark | Recruiting |
| Department of Gynecology and Obstetrics, Aarhus University Hospital | Aarhus, Aarhus N, Denmark | Not Yet Recruiting |
| Steno Diabetes Center Aarhus | Aarhus, Aarhus N, Denmark | Not Yet Recruiting |
| Steno Diabetes Center Nordjylland | Aalborg, Gistrup, Denmark | Recruiting |
| Steno Diabetes Center Copenhagen | Copenhagen, Herlev, Denmark | Not Yet Recruiting |
| Department of Gynecology and Obstetrics, Odense University Hospital | Odense, Odense C, Denmark | Recruiting |
| Steno Diabetes Center Odense, Odense University Hospital | Odense, Odense C, Denmark | Recruiting |
| Center for Pregnant Women with Diabetes, Rigshospitalet | Copenhagen, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07240012